The role of adenosine receptor ligands on inflammatory pain: possible modulation of TRPV1 receptor function

被引:12
|
作者
Haddad, Mansour [1 ]
Alsalem, Mohammad [2 ]
Aldossary, Sara A. A. [4 ]
Kalbouneh, Heba [2 ]
Jaffal, Sahar M. M. [5 ]
Alshawabkeh, Qusai [2 ]
Al Hayek, Sa'ed [2 ]
Abdelhai, Omar [6 ]
Barakat, Noor A. A. [2 ]
El-Salem, Khalid [3 ]
机构
[1] Yarmouk Univ, Fac Pharm, Irbid 21163, Jordan
[2] Univ Jordan, Sch Med, Amman 11942, Jordan
[3] Jordan Univ Sci & Technol, Fac Med, Irbid 22110, Jordan
[4] King Faisal Univ, Fac Clin Pharm, Al Hasa, Saudi Arabia
[5] Univ Jordan, Fac Sci, Biol Sci, Amman 11942, Jordan
[6] Al Khalidi Hosp & Med Ctr, Ibn Khaldon St 39, Amman, Jordan
关键词
Pain; Adenosine receptors; Inflammation; TRPV1; SPINAL-CORD; NEUROPATHIC PAIN; MICE LACKING; CAPSAICIN RECEPTOR; ACTIVATION; AGONISTS; FORMALIN; A(1); ANTINOCICEPTION; INHIBITION;
D O I
10.1007/s10787-022-01127-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic pain has a debilitating consequences on health and lifestyle. The currently available analgesics are often ineffective and accompanied by undesirable adverse effects. Although adenosine receptors (AR) activation can affect nociceptive, inflammatory, and neuropathic pain states, the specific regulatory functions of its subtypes (A(1), A(2A), A(2B) and A(3) ARs) are not fully understood. The aim of this study was to investigate the role of different AR ligands on inflammatory pain. The von Frey filament test was used to assess the anti-nociceptive effects of adenosine ligands on Complete Freund's Adjuvant (CFA)-induced mechanical allodynia in (180-220 g) adult male Sprague Dawley rats (expressed as paw withdrawal threshold, PWT). Neither the A(2A)AR selective agonist CGS 21680 hydrochloride (0.1, 0.32 and 1 mg/kg) nor the A(2B)AR selective agonist BAY 60-6583 (0.1, 0.32 and 1 mg/kg) produced any significant reversal of the PWT. However, the A(1)AR selective agonist ( +/-)-5'-Chloro-5'-deoxy-ENBA, the A(3)AR selective agonist 2-Cl-IB-MECA, the A(2A)AR selective antagonist ZM 241385 and the A(2B)AR selective antagonist PSB 603 produced a significant reversal of the PWT at the highest dose of 1 mg/kg. Co-administration of the selective antagonists of A(1)AR and A(3)AR PSB36 (1 mg/ml) and MRS-3777 (1 mg/ml); respectively, significantly reversed the anti-nociceptive effects of their corresponding agonists. Furthermore, calcium imaging studies reveled that the effective AR ligands in the behavioral assay also significantly inhibit capsaicin-evoked calcium responses in cultured rat dorsal root ganglia (DRG) neurons. In conclusion, modulating the activity of the transient receptor potential vanilloid 1 (TRPV1) receptor by ARs ligands could explain their anti-nociceptive effects observed in vivo. Therefore, the cross talk between ARs and TRPV1 receptor may represent a promising targets for the treatment of inflammatory pain conditions.
引用
收藏
页码:337 / 347
页数:11
相关论文
共 50 条
  • [41] Felodipine repurposed for targeting TRPV1 receptor to relieve oral cancer pain
    Yadalam, Pradeep Kumar
    Anegundi, Raghavendra Vamsi
    Ramadoss, Ramya
    Joseph, Betsy
    Veeramuthu, AshokKumar
    ORAL ONCOLOGY, 2022, 134
  • [42] Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain
    Ghilardi, JR
    Röhrich, H
    Lindsay, TH
    Sevcik, MA
    Schwei, MJ
    Kubota, K
    Halvorson, KG
    Poblete, J
    Chaplan, SR
    Dubin, AE
    Carruthers, NI
    Swanson, D
    Kuskowski, M
    Flores, CM
    Julius, D
    Mantyh, PW
    JOURNAL OF NEUROSCIENCE, 2005, 25 (12): : 3126 - 3131
  • [43] Monoacylglycerols activate capsaicin receptor, TRPV1
    Iwasaki, Yusaku
    Saito, Orine
    Tanabe, Manabu
    Inayoshi, Kimiko
    Kobata, Kenji
    Uno, Shuichi
    Morita, Akihito
    Watanabe, Tatsuo
    LIPIDS, 2008, 43 (06) : 471 - 483
  • [44] Increased Capsaicin Receptor TRPV1 in the Peritoneum of Women With Chronic Pelvic Pain
    Poli-Neto, Omero Benedicto
    Adhor Filho, Antonio
    Rosa e Silva, Julio Cesar
    Barbosa, Hermes de Freitas
    Candido Dos Reis, Francisco Jose
    Nogueira, Antonio Alberto
    CLINICAL JOURNAL OF PAIN, 2009, 25 (03): : 218 - 222
  • [45] The pain receptor TRPV1 displays agonist-dependent activation stoichiometry
    Adina Hazan
    Rakesh Kumar
    Henry Matzner
    Avi Priel
    Scientific Reports, 5
  • [46] Novel, potent TRPV1 receptor antagonists
    Brown, Brian S.
    Keddy, Ryan G.
    Zheng, Guo Zhu
    Schmidt, Robert G.
    Koenig, John Robert
    Honore, Prisca
    Jarvis, Michael F.
    Surowy, Carol S.
    Faltynek, Connie R.
    Lee, Chih-Hung
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2545 - U2546
  • [47] The role of transient receptor potential vanilloid 1 (TRPV1) channels in pancreatitis
    Liddle, Rodger A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (08): : 869 - 878
  • [48] The pain receptor TRPV1 displays agonist-dependent activation stoichiometry
    Hazan, Adina
    Kumar, Rakesh
    Matzner, Henry
    Priel, Avi
    SCIENTIFIC REPORTS, 2015, 5
  • [49] The TRPV1 receptor: Target of toxicants and therapeutics
    Veronesi, B
    Oortgiesen, M
    TOXICOLOGICAL SCIENCES, 2006, 89 (01) : 1 - 3
  • [50] Receptor activity and conformational analysis of 5′-halogenated resiniferatoxin analogs as TRPV1 ligands
    Lim, Kwang Su
    Kang, Dong Wook
    Kim, Yong Soo
    Kim, Myeong Seop
    Park, Seul-Gi
    Choi, Sun
    Pearce, Larry V.
    Blumberg, Peter M.
    Lee, Jeewoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 299 - 302